Samantha Prout L.'s most recent trade in Amicus Therapeutics Inc was a trade of 27,416 Common Stock done . Disclosure was reported to the exchange on Feb. 11, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 27,416 | 122,941 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 13,500 | 109,441 (0%) | 0% | 9.6 | 129,195 | Common Stock |
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 62,715 | 62,715 | - | - | Stock Options (right to buy) | |
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 34,614 | 105,097 (0%) | 0% | 0 | Common Stock | |
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 8,275 | 96,822 (0%) | 0% | 9.4 | 77,868 | Common Stock |
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.31 per share. | 02 Jan 2025 | 3,443 | 70,483 (0%) | 0% | 9.3 | 32,054 | Common Stock |
Amicus Therapeutics Inc | Samantha Prout L. | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 1,297 | 95,525 (0%) | 0% | 9.4 | 12,205 | Common Stock |